DOSE OF REALITY: BIOSIMILAR COMPETITION GENERATES SIGNIFICANT SAVINGS FOR PATIENTS AND THE U.S. HEALTH CARE SYSTEM
May 2, 2024
Reports Find Biosimilars Have Lower Prices Than Brand Name Biologics… Read More
© 2025 CSRXP- All Rights Reserved
Updates
CSRXP APPLAUDS EXPANDED FTC CRACK DOWN ON BIG PHARMA’S SHAM PATENTS IN THE ORANGE BOOK
Apr 30, 2024
Commission Builds on Previous Action by Targeting More Than 300 Patents,… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS, MERCK, ASTRAZENECA, BRISTOL MYERS SQUIBB AND SANOFI
Apr 26, 2024
Big Pharma Continues Raking in Big Profits and Expectation-Beating Revenue… Read More
DOSE OF REALITY: NEW ANALYSES UNDERSCORE HOW BIG PHARMA’S EGREGIOUS PRICING OF WEIGHT LOSS DRUGS IS UNSUSTAINABLE
Apr 25, 2024
Two Reports Explore Cost for U.S. Patients and the U.S. Health Care System of… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 19, 2024
Big Pharma Giant Kicks Off Q1 Earnings After Hiking Prices More Than 40 Times… Read More
SECOND OPINION: BIG PHARMA’S OUT-OF-POCKET PLANS ON BRAND NAME INHALERS MAY BE DESIGNED TO FURTHER UNDERMINE COMPETITION
Apr 8, 2024
Big Pharma’s Announcements Designed to Deflect from Criticism and Scrutiny… Read More
CSRXP COMMENDS PRESIDENT BIDEN FOR HOLDING BIG PHARMA ACCOUNTABLE FOR PATENT ABUSE AND EGREGIOUS PRICING ON BRAND NAME INHALERS
Apr 3, 2024
President Says ‘Drug Companies Are Charging Exorbitant Prices’ in Press… Read More
Dose of Reality: CBO Confirms Big Pharma’s Egregious Prices on Weight Loss Drugs Are Unsustainable
Mar 22, 2024
CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings… Read More
THEN VS. NOW: PFIZER LATEST BIG PHARMA GIANT TO ACCIDENTALLY DEBUNK INDUSTRY’S OWN DOOM-AND-GLOOM INNOVATION RHETORIC
Mar 7, 2024
Big Pharma Exec Downplays “Modest” Drug Pricing Solutions That CEO… Read More
BIG PHARMA WATCH: BIG PHARMA SET NEW RECORD FOR OUT-OF-CONTROL LAUNCH PRICES IN 2023, UP 35 PERCENT FROM PREVIOUS YEAR
Feb 26, 2024
Median Price Set by Brand Name Drug Makers on New Treatments Climbs to… Read More
BIG PHARMA EARNINGS WATCH: ELI LILLY AND NOVO NORDISK
Feb 22, 2024
GLP-1 Weight-Loss Leaders “Blow Past” Wall Street Projections in Q4 2023,… Read More
BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB AND ABBVIE
Feb 15, 2024
More Big Pharma Giants Report Earnings That Top Wall Street Expectations While… Read More